Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug combo aims to tame deadly fat levels and stop pancreas attacks

NCT ID NCT07308392

First seen Jan 06, 2026 · Last updated May 23, 2026 · Updated 28 times

Summary

This study tests two experimental drugs, HRS-7249 and SHR-1918, in 108 adults with dangerously high triglycerides who are at risk for acute pancreatitis. The goal is to see if the drugs can safely lower fat levels in the blood and reduce the chance of a pancreatitis attack. Participants will receive either the drugs or a placebo, and researchers will track their triglyceride levels and any pancreatitis events over about 48 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE HYPERTRIGLYCERIDEMIA WITH A HIGH RISK OF ACUTE PANCREATITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

    RECRUITING

    Nanjing, Jiangsu, 210029, China

    Contact

Conditions

Explore the condition pages connected to this study.